Evidence map›Paper›PMID 33291536›Full record

ArticleInternational journal of molecular sciences2020

The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple Sclerosis.

Lars Masanneck, Susann Eichler, Anna Vogelsang, Melanie Korsen, Heinz Wiendl, Thomas Budde, Sven G Meuth

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Multiple Sclerosis: Inflammatory and Neuroglial Aspects.Current issues in molecular biology · 2023
    Review
  13. Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders.International journal of molecular sciences · 2022
    Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lars MasanneckDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
Susann EichlerDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
Anna VogelsangDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
Melanie KorsenDepartment of Neurology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Heinz WiendlDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
Thomas BuddeInstitute of Physiology I, University of Münster, 48149 Münster, Germany.
Sven G MeuthDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
University Hospital Münster · DEHeinrich Heine University Düsseldorf · DEUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic GMP-AMP-synthase is a sensor of endogenous nucleic acids, which subsequently elicits a stimulator of interferon genes (STING)-dependent type I interferon (IFN) response defending us against viruses and other intracellular pathogens. This pathway can drive pathological inflammation, as documented for type I interferonopathies. In contrast, specific STING activation and subsequent IFN-β release have shown beneficial effects on experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Although less severe cases of relapse-remitting MS (RRMS) are treated with IFN-β, there is little information correlating aberrant type I IFN signaling and the pathologic conditions of MS. We hypothesized that there is a link between STING activation and the endogenous production of IFN-β during neuroinflammation. Gene expression analysis in EAE mice showed that

Indexed as

Signal TransductionBiomarkersCentral Nervous SystemDisease SusceptibilityFlow CytometryGene ExpressionHumansInterferon-betaLeukocytes, MononuclearMembrane ProteinsMultiple Sclerosis, Relapsing-RemittingMyeloid CellsSTING ProteinBiomarkersInterferon-betaMembrane ProteinsSTING1 protein, humanSTING ProteincGAMPEAEinterferon-betamultiple sclerosisRRMSSTING

Identifiers

PMID33291536
PMCPMC7730283
OpenAlexW3108711061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.